Lung immune signatures define two groups of end-stage IPF patients.
Cruz T, Mendoza N, Casas-Recasens S, Noell G, Hernandez-Gonzalez F, Frino-Garcia A, Alsina-Restoy X, Molina M, Rojas M, Agustí A, Sellares J, Faner R.
Cruz T, et al.
Respir Res. 2023 Sep 28;24(1):236. doi: 10.1186/s12931-023-02546-8.
Respir Res. 2023.
PMID: 37770891
Free PMC article.